Topical small-molecule inhibitor of the mitochondrial pyruvate carrier (MPC), in Phase 2 clinical development by Pelage Pharmaceuticals for androgenetic alopecia. Proposed mechanism shifts hair follicle stem cell metabolism to promote anagen (growth-phase) reentry.
For research purposes only. Not medical advice.
2 research peptide vendors currently list PP405 (JXL-069) on PeptideScouter. We track 2 active listings across size and kit variants.
PP405 (JXL-069)'s CAS Registry Number is 2260696-63-5. It is also sold as PP-405, JXL-069, PP405 (JXL-069).